Form D · Other Health Care

Nuwellis, Inc.

Eden Prairie, MN · CIK 0001506492

Offering snapshot reported Nov 20, 2024 · SEC filing

Reported sold
$3.85M
Offering amount: $3.85M
Investors reported
9
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 6, 2024
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Nov 20, 2024Initial$3,848,286No comparison9SEC filing
Sep 4, 2024Initial$0No comparison6SEC filing
Aug 2, 2024Initial$0No comparison7SEC filing
Jun 26, 2023Initial$0No comparison1SEC filing
May 7, 2020Initial$1,699,998No comparison4SEC filing
Apr 8, 2020Initial$2,226,519No comparison4SEC filing
Mar 30, 2020Initial$1,248,418No comparison4SEC filing
Nov 21, 2019Initial$1,365,300No comparison3SEC filing
Nov 1, 2019Initial$663,000No comparison2SEC filing
Feb 27, 2017Initial$563,863No comparison2SEC filing
Jan 25, 2017Initial$200,000No comparison2SEC filing
Nov 9, 2016Initial$3,600,000No comparison2SEC filing
Aug 18, 2016Initial$950,000No comparison1SEC filing
Aug 2, 2016Initial$3,468,000No comparison2SEC filing
Mar 2, 2015Initial$360,000No comparison2SEC filing
May 20, 2013Initial$1,500,000No comparison1SEC filing
Sep 19, 2012Initial$700,000No comparison2SEC filing
Feb 22, 2012Initial$2,112,769No comparison4SEC filing
Aug 10, 2011Initial$4,969,631No comparison9SEC filing
Nov 24, 2010Initial$3,500,000No comparison7SEC filing

Offering details

Securities
Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$383K (estimated)
Finders' fees
$0
Form D file number
021-529957
In connection with a warrant inducement offering, warrants to purchase up to 3,720,010 shares of common stock were issued in a private placement. The offering amount excludes proceeds of up to $7,300,658 from the exercise of the warrants.
A fee equal to 8% of the gross proceeds received from the Inducement Offer will be paid to the placement agent, along with legal fees and expenses, and warrants to purchase up to 54,976 shares of common stock at an exercise price of $3.465.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Ladenburg Thalmann & Co. Inc.505

Source: Form D, filed Nov 20, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Neil P. Ayotte Executive
Kevin P. Bassett Executive
Lynn Larson Blake Executive
Steven Brandt Director
Steve Brandt Director
John Brennan Director
Geoffrey E. Brooke Director
Brian Brown Executive
Paul Buckman Director
Nicholas Callinan Director
Maria Rosa Costanzo Director
Maria Rosa Costanzo, M.D. Director
Claudia Drayton Executive
John L. Erb Director
Archelle Georgiou, M.D. Director
Mark Harvey Director
Rowena Hubble Executive
Nestor Jaramillo Director, Executive
Nestor Jaramillo, Jr. Director, Executive
Debra J. Kridner Executive
Matthew Likens Director
Eric Lovett Executive
Crispin Marsh Director
Jeffrey S. Mathiesen Executive
Mike Mc Cormick Director
Michael Kendrick Mc Cormick Director
Dave Kendrick Mc Donald Director
Donal O'dwyer Director
Kimberly Oleson Executive
William S. Peters Executive
David A. Rosa Director, Executive
John W. Salveson Director
Jon Salveson Director
Rob Scott Executive
Molly Wade Executive
Gregory Waller Director
Warren S. Watson Director
Jim Yearick Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
12988 Valley View Road
Eden Prairie, MN, 55344